Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

Fintel reports that on November 15, 2024, B of A Securities downgraded their outlook for bluebird bio (NasdaqGS:BLUE) from ...

A virologist named Beata Halassy recently made headlines after publishing a report of successfully treating her own breast ...

Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...

The two leaders will meet in Peru, where China has steadily expanded its influence in a challenge to the United States in its own region. By David Pierson and Mitra Taj Displaced young ...

The Ukrainian president also said his country "must do everything" to ensure the war ends next year. The president-elect's picks for defence secretary, attorney general and health secretary are ...

Under the Chandelier at Mar-a-Lago, Trump Makes Picks at Breakneck Speed President-elect Trump is more contemptuous than ever of Washington expertise and determined to hire people based on loyalty ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...